Increased expression of Ob-Rb and its relationship with the overexpression of TGF-β1 and the stage of fibrosis in patients with nonalcoholic steatohepatitis

Liver International

Volumn 26, Issue 9, 2006, Pages 1065-1071

  Cayon A ^a   Crespo, Javier ^a   Mayorga, M ^a   Guerra, A ^a   Pons Romero, F ^a  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

Author keywords

Leptin; Leptin receptor; NASH; Nonalcoholic steatohepatitis; Ob Rb; TGF

Indexed keywords

LEPTIN; LEPTIN RECEPTOR; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; ANTHROPOMETRY; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DATA ANALYSIS; DISEASE SEVERITY; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; HYPERLEPTINEMIA; IMMUNOHISTOCHEMISTRY; LIVER FIBROSIS; LIVER PARENCHYMA; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; RADIOIMMUNOASSAY; REAL TIME POLYMERASE CHAIN REACTION; STATISTICAL SIGNIFICANCE; STEATOSIS;

ADULT; FATTY LIVER; FEMALE; GENE EXPRESSION; HUMANS; LEPTIN; LIVER; LIVER CIRRHOSIS; MALE; MIDDLE AGED; RECEPTORS, CELL SURFACE; RECEPTORS, LEPTIN; RNA, MESSENGER; SEVERITY OF ILLNESS INDEX; TRANSFORMING GROWTH FACTOR BETA1;

EID: 33749627688     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2006.01337.x     Document Type: Article

References (22)

1. Sanyal A G. AGA technical review on nonalcoholic fatty liver disease. Gastroenterology 2002; 123: 1705-25.
2. Henriksen J H, Holst J J, Moller S, Brinch K, Bendtsen F. Increased circulating leptin in alcoholic cirrhosis: Relation to release and disposal. Hepatology 1999; 29: 1818-24.
3. McCullough A J, Bugianesi E, Marchesini G, Kalhan S C. Gender-dependent alterations in serum leptin in alcoholic cirrhosis. Gastroenterology 1998; 115: 947-53.
4. Garcia-Suarez C, Crespo J, Fernandez-Gil P L, Amado J A, Garcia-Unzueta M T, Pons Romero F. Plasma leptin levels in patients with primary biliary cirrhosis and their relationship with degree of fibrosis. Gastroenterol Hepatol 2004; 27: 47-50.
5. Crespo J, Rivero M, Fabrega E, et al. Plasma leptin and TNF-alpha levels in chronic hepatitis C patients and their relationship to hepatic fibrosis. Dig Dis Sci 2002; 47: 1604-10.
6. Tang M, Potter J J, Mezey E. Leptin enhances the effect of transforming growth factor beta in increasing type I collagen formation. Biochem Biophys Res Commun 2002; 297: 906-11.
7. Ikejima K, Takei Y, Honda H, et al. Leptin receptor-mediated signaling regulates hepatic profibrogenic and remodeling of extracellular matrix in the rat. Gastroenterology 2002; 122: 1399-410.
8. Potter J J, Womack L, Mezey E, Anania F A. Transdifferentiation of rat hepatic stellate cells results in leptin expression. Biochem Biophys Res Commun 1998; 244: 178-82.
9. Chitturi S, Farrell G, Frost L, et al. Serum leptin in NASH correlates with hepatic steatosis but not fibrosis: A manifestation of lipotoxicity? Hepatology 2002; 36: 403-9.
10. Brunt E M, Janney C G, Di Bisceglie A M, Neuschwander-Tetri B A, Bacon B R. Nonalcoholic steatohepatitis: A proposal for grading and staging the histological lesions. Am J Gastroenterol 1999; 94: 2467-74.
11. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-9.
12. Considine R V, Sinha M K, Heiman M L, et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 1996; 334: 292-5.
13. Uygun A, Kadayifci A, Yesilova Z, et al. Serum leptin levels in patients with nonalcoholic steatohepatitis. Am J Gastroenterol 2000; 95: 3584-9.
14. Chalasani N, Crabb D W, Cummings O W, et al. Does leptin play a role in the pathogenesis of human nonalcoholic steatohepatitis? Am J Gastroenterol 2003; 98: 2771-6.
15. Marchesini G, Bugianesi E, Forlani G, et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 2003; 37: 917-23.
16. Neuschwander-Tetri B A, Caldwell S H. Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. Hepatology 2003; 37: 1202-19.
17. Hui J M, Hodge A, Farrell G C, Kench J G, Kriketos A, George J. Beyond insulin resistance in NASH: tNF-alpha or adiponectin? Hepatology 2004; 40: 46-54.
18. Hickman I J, Powell E E, Prins J B, et al. In overweight patients with chronic hepatitis C, circulating insulin is associated with hepatic fibrosis: Implications for therapy. J Hepatol 2003; 39: 1042-8.
19. Otte C, Otte J M, Strodthoff D, et al. Expression of leptin and leptin receptor during the development of liver fibrosis and cirrhosis. Exp Clin Endocrinol Diabetes 2004; 112: 10-7.
20. Leask A, Abraham D J. TGF-beta signaling and the fibrotic response. FASEB J 2004; 18: 816-27.
21. Bissell D M, Roulot D, George J. Transforming growth factor beta and the liver. Hepatology 2001; 34: 859-67.
22. Taniguchi H, Kato N, Otsuka M, et al. Hepatitis C virus core protein upregulates transforming growth factor-beta 1 transcription. J Med Virol 2004; 72: 52-9.